MSLN and neoplasm: The thorium-227 anti-mesothelin monoclonal antibody conjugate radiopharmaceutical uses a 3,2-HOPO chelate to house thorium-227 and link it to a tumor-targeting antibody, and in this case, against mesothelin (13).